ArticleEClinicalMedicine2025

Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial.

Chao-Yi Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.